- Home
- ACHC vs IDYA Comparison
ACHC vs IDYA Comparison
Compare ACHC & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ACHC | IDYA |
|---|---|---|
| Founded | 2005 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.6B |
| IPO Year | 2011 | 2019 |
Fundamental Metrics
Financial Performance| Metric | ACHC | IDYA |
|---|---|---|
| Price | $24.29 | $34.94 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 15 | 16 |
| Target Price | $22.67 | ★ $52.86 |
| AVG Volume (30 Days) | ★ 2.2M | 1.2M |
| Earning Date | 04-29-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 61.90 |
| EPS | ★ 0.05 | N/A |
| Revenue | ★ $3,312,769,000.00 | $218,710,000.00 |
| Revenue This Year | $5.08 | N/A |
| Revenue Next Year | $5.98 | $201.05 |
| P/E Ratio | $504.20 | ★ N/A |
| Revenue Growth | 5.04 | ★ 3024.43 |
| 52 Week Low | $11.43 | $20.50 |
| 52 Week High | $30.20 | $39.28 |
Technical Indicators
Market Signals| Indicator | ACHC | IDYA |
|---|---|---|
| Relative Strength Index (RSI) | 47.17 | 69.60 |
| Support Level | $22.05 | $32.85 |
| Resistance Level | $25.14 | $36.01 |
| Average True Range (ATR) | 1.17 | 1.80 |
| MACD | 0.04 | 0.67 |
| Stochastic Oscillator | 23.20 | 92.17 |
Price Performance
Historical ComparisonAbout ACHC Acadia Healthcare Company Inc.
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Its facilities and services are classified into the following categories: acute inpatient psychiatric facilities; specialty treatment facilities; CTCs; and residential treatment centers. In which Acute inpatient psychiatric facilities contribute the majority of revenue in the United States. The Company has one reportable segment, behavioral healthcare services. The behavioral healthcare services segment provides inpatient and outpatient behavioral healthcare services.
About IDYA IDEAYA Biosciences Inc.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.